CimCure
Amsterdam, NL · 1 known investors
CimCure develops active cancer vaccines that use its proprietary Immune-Boost (iBoost) technology to prompt the body to produce antibodies that attack and destroy the blood vessels feeding solid tumours, stopping cancer growth. Founded as a spin-off from the Angiogenesis Laboratory at Amsterdam UMC, the biotech company targets all types and stages of solid tumours.
Founders & leadership
AG
Arjan GriffioenCo-founder & Chief Scientific Officer
DE
Diederik EngbersenCEO
Investors · 1
Frequently asked questions
- What does CimCure do?
- CimCure develops active cancer vaccines that use its proprietary Immune-Boost (iBoost) technology to prompt the body to produce antibodies that attack and destroy the blood vessels feeding solid tumours, stopping cancer growth. Founded as a spin-off from the Angiogenesis Laboratory at Amsterdam UMC, the biotech company targets all types and stages of solid tumours.
- Who founded CimCure?
- CimCure was founded by Arjan Griffioen.
- Who are CimCure's investors?
- CimCure's investors include Positron Ventures.
- Where is CimCure headquartered?
- CimCure is headquartered in Amsterdam, NL.